N-able Inc (NYSE: NABL) Down -16.81% YTD: Could Trouble Be Ahead?
N-able Inc (NYSE:NABL)’s traded shares stood at 0.79 million during the last session, with the company’s beta value hitting 0.62. At the close of trading,
N-able Inc (NYSE:NABL)’s traded shares stood at 0.79 million during the last session, with the company’s beta value hitting 0.62. At the close of trading,
East West Bancorp, Inc (NASDAQ:EWBC)’s traded shares stood at 0.76 million during the last session, with the company’s beta value hitting 0.91. At the close
Niagen Bioscience Inc (NASDAQ:NAGE)’s traded shares stood at 0.88 million during the last session, with the company’s beta value hitting 2.10. At the close of
Tanger Inc (NYSE:SKT)’s traded shares stood at 0.7 million during the last session, with the company’s beta value hitting 1.18. At the close of trading,
Jackson Financial Inc (NYSE:JXN)’s traded shares stood at 0.78 million during the last session, with the company’s beta value hitting 1.47. At the close of
Rentokil Initial Plc. ADR (NYSE:RTO)’s traded shares stood at 0.89 million during the last session, with the company’s beta value hitting 0.96. At the close
Corvus Pharmaceuticals Inc (NASDAQ:CRVS)’s traded shares stood at 0.76 million during the last session, with the company’s beta value hitting 0.58. At the close of
PDS Biotechnology Corporation (NASDAQ:PDSB)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting 1.26. At the close of
FingerMotion Inc (NASDAQ:FNGR)’s traded shares stood at 0.35 million during the last session, with the company’s beta value hitting -0.63. At the close of trading,
BBVA Argentina ADR (NYSE:BBAR)’s traded shares stood at 0.75 million during the last session, with the company’s beta value hitting 1.28. At the close of
© 2024, Powered by Smart TechOne